COVID-19 and Osteoporosis
Live Webinar: 14 January November 2021, 4pm CET
Additional Live Coffee Shop: 14 January November 2021, 5pm CET
ECTS is pleased to let you know that Nicola Napoli will be available for a “Coffee Shop” informal discussion at 5pm CET, right after the live webinar. If you are interested in this networking opportunity, please register for the live webinar and the additional Zoom link for this Coffee Shop will be sent in the confirmation email as well as in a reminder sent 2 hours in advance of the webinar.View Webcast
Organised by ECTS.
Date & Time: 14 January 2021, 4pm CET
Featuring Nicola Napoli, and moderated by Nadia Rucci
Costs: Live webinar is free for ECTS members and non-members, but a registration is required. Recordings are accessible to ECTS members only.
- 5 min welcome & introductions
- 35 min presentation on COVID-19 and Osteoporosis
- 20 min Q&A
- The role of bone fragility on the clinical outcomes in COVID-19 patients
- The importance of vitamin D status on the severity of COVID-19 infection
- Challenges for the management of osteoporosis and fracture care in COVID-19 patients
Featuring Nicola Napoli
Dr Nicola Napoli received his medical degree in 2000 and completed his clinical fellowship and PhD in Metabolic Diseases at Washington University in St Louis. He is Associate Professor of Endocrinology at University Campus Bio-Medico of Rome and Adjunct Faculty at Washington University in ST Louis. He is a passionate physician, involved in the clinical care of patients with endocrine, metabolic and bone disorders in both hospital and outpatient clinical settings. His research focuses on pathophysiology of bone fragility in diabetes, anti-osteoporosis treatment, fracture risk management, atypical femur fractures. He has been co-founder of ECTS Bone Academy, chair of the MEE committee of the ASBMR, clinical advisor of the IOF. He serves as Associate Editor of Journal of Clinical Endocrinology & Metabolism and Endocrine and as bone leader for the steering committee of the Endocrine Society. He has been funded by Italian and European research programs and received several research awards by national and International Societies.
Moderated by Nadia Rucci
Present position: Associate Professor and head of the Skeletal Diseases Laboratory at the Department of Biotechnological and Applied Clinical Sciences (DISCAB), University of L’Aquila, Italy.
Degrees: (2003) School of Specialization in Clinical Pathology, University of L’Aquila; (1999) PhD in Endocrinology and Metabolic Diseases, University of L’Aquila; (1994) Bachelor’s in Biology, University “La Sapienza”, Rome, Italy.
Awards: (2009) International Bone Research Association (IBRA) Robert Schenk Research Prize; (2004) Novartis Young Investigator Award, European Symposium on Calcified Tissues; (2003) Novartis Young Investigator Award, European Symposium on Calcified Tissues, Rome, Italy; (2001) Travel grant, International Bone and Mineral Society and European Calcified Tissue Society.
Research: Prof. Rucci research’s is mainly focused on oncologic (breast cancer induced bone metastases), metabolic (osteoporosis) and genetic (osteopetrosis) bone diseases. Nadia is currently PI of two projects: “Extracellular vesicles as new therapeutic approach to target bone tumour cells” funded by the Italian Association of Cancer Research and “Bone phenotype in Duchenne muscular dystrophy: unveiling the role of LCN2 and implications for therapy” funded by AFM-Telethon. She has published 79 original research articles in peer-review international journals.